Tricida Inc.

Plus: Coya promotes Arun Swaminathan to CEO, and updates from Tempest and Incyclix

Plus: Summit hires Manmeet Soni as COO, and updates from SwanBio, DBV, Lyra and EyePoint

At year-end, twice as many of the companies had lost value since their IPOs than gained value 

Biotech struck by a wave of downsizing, restructuring and closures, as companies run out of options in an unforgiving market

Winners, losers across biotech market cap tiers in 4Q22

Plus: Oramed’s oral insulin misses in diabetes and Tricida going bankrupt

Plus Alpine pivots and updates from Resolve, Imjudo, Syncona and more

Plus Chan Lee to be general counsel at BeiGene and updates from CytoDyn, Kezar, Anaveon, Fulcrum and more

Plus Cambrian seeds women’s health subsidiary and updates from Pfizer, Tricida and more

Plus Biogen starts layoffs and updates from Roche, ArrePath, NuCana, Tricida and more